STAAR Surgical Company

STAA ·Healthcare, Medical Devices, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2026 FY2024 FY2023 FY2022 FY2021 FY2020 FY2018 FY2017
Assets
Cash & Equivalents $153.2M $144.2M $183.0M $86.5M $199.7M $120.0M $103.9M $18.5M
Accounts Receivable $50.1M $77.9M $94.7M $62.4M $43.5M $31.0M $25.9M $17.9M
Inventory — — — — — — — —
Total Current Assets $311.5M $367.9M $365.3M $311.7M $271.4M $174.7M $151.6M $53.9M
Property, Plant & Equipment $73.3M $84.9M $66.8M $50.9M $35.9M $17.1M $11.5M $9.8M
Goodwill $1.8M $1.8M $1.8M $1.8M $1.8M $1.8M $1.8M $1.8M
Intangible Assets (Excl. Goodwill) — — — $173.0K $218.0K $296.0K $243.0K $271.0K
Total Assets $451.7M $509.5M $488.7M $418.8M $345.8M $207.5M $167.3M $67.9M
Liabilities
Accounts Payable $11.6M $16.7M $13.6M $11.6M $8.7M $8.1M $6.5M $6.0M
Total Current Liabilities $68.5M $70.3M $65.0M $51.7M $48.8M $34.5M $27.7M $19.1M
Long-Term Debt — — — — — — — —
Total Liabilities $107.5M $112.2M $102.7M $82.7M $87.2M $47.6M $34.9M $25.0M
Stockholders' Equity
Retained Earnings $-148.0M $-67.6M $-47.4M $-68.7M $-111.4M $-141.8M $-156.3M $-161.2M
Total Stockholders' Equity $344.2M $397.3M $386.0M $336.1M $261.6M $159.9M $132.4M $42.9M
← Newer Page 1 of 2 Older →